BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16613992)

  • 1. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase.
    Siriwardana G; Bradford A; Coy D; Zeitler P
    Mol Endocrinol; 2006 Sep; 20(9):2010-9. PubMed ID: 16613992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone.
    Zeitler P; Siriwardana G
    Endocrine; 2000 Jun; 12(3):257-64. PubMed ID: 10963046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-releasing hormone stimulates mitogen-activated protein kinase.
    Pombo CM; Zalvide J; Gaylinn BD; Diéguez C
    Endocrinology; 2000 Jun; 141(6):2113-9. PubMed ID: 10830298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.
    Barabutis N; Tsellou E; Schally AV; Kouloheri S; Kalofoutis A; Kiaris H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5575-9. PubMed ID: 17372203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GHRH proliferative action on somatotrophs is cell-type specific and dependent on Pit-1/GHF-1 expression.
    Solloso A; Barreiro L; Seoane R; Nogueira E; Cañibano C; Alvarez CV; Zalvide J; Diéguez C; Pombo CM
    J Cell Physiol; 2008 Apr; 215(1):140-50. PubMed ID: 17941086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
    Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
    Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
    Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
    Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
    Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.
    Barabutis N; Siejka A; Schally AV; Block NL; Cai R; Varga JL
    J Mol Endocrinol; 2010 Feb; 44(2):127-34. PubMed ID: 19897610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.
    Florea V; Majid SS; Kanashiro-Takeuchi RM; Cai RZ; Block NL; Schally AV; Hare JM; Rodrigues CO
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17260-5. PubMed ID: 25404316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor.
    Veyrat-Durebex C; Pomerleau L; Langlois D; Gaudreau P
    J Cell Physiol; 2005 May; 203(2):335-44. PubMed ID: 15499571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of the breast cancer-promoter hormone, 5α-dihydroprogesterone (5αP), involves plasma membrane-associated receptors and MAPK activation.
    Wiebe JP; Pawlak KJ; Kwok A
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):166-76. PubMed ID: 26519986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
    Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
    Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the pituitary somatotroph cell by GHRH and its receptor.
    Mayo KE; Miller T; DeAlmeida V; Godfrey P; Zheng J; Cunha SR
    Recent Prog Horm Res; 2000; 55():237-66; discussion 266-7. PubMed ID: 11036940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.